One form of liver steatosis, namely Non-Alcoholic Fatty Liver Disease (NAFLD), is a worrisome health problem worldwide characterized by intrahepatic triacylglycerol (TG) overaccumulation. NAFLD is a common feature of metabolic syndrome being often associated with obesity, dyslipidemia and diabetes and mostly closely linked to insulin resistance. The mechanism of NAFLD pathogenesis is object of intense investigation especially regarding complex systems ultimately resulting in excessive TG deposition in hepatocytes. However, scarce is the attention about the relevance of hepatic import of glycerol, the other primary source (as glycerol-3-phosphate) of increased TG in hepatocytes. Obese leptin-deficient (ob/ob) mice, an animal model of NAFLD, were used to evaluate the functional involvement of Aquaporin-9 (AQP9), the major pathway of liver glycerol entry, in hepatosteatosis. By RT-PCR and qPCR, the level of Aqp9 mRNA in the liver of starved obese mice was comparable with the corresponding control lean littermates. By immunoblotting, the AQP9 protein at the hepatocyte sinusoidal plasma membrane of obese mice was markedly lower (33%) than lean mice, a finding fully confirmed by immunohistochemistry. By stopped-flow light scattering, the liver glycerol permeability of ob/ob mice was significantly lower (53%) than lean mice, a finding consistent with both the observed down-regulation of AQP9 protein and increased level of plasma glycerol characterizing obese mice. In summary, our results suggest implication of AQP9 in liver steatosis. The reduction of hepatocyte AQP9 and, consequently, glycerol permeability might be a defensive mechanism to counteract further fat infiltration in liver parenchyma.
References
[1]
Tiniakos DG, Vos MB, Brunt EM (2010) Nonalcoholic fatty liver disease: pathology and pathogenesis. Annu Rev Pathol 5: 145–171.
[2]
Love-Osborne KA, Nadeau KJ, Sheeder J, Fenton LZ, Zeitler P (2008) Presence of the metabolic syndrome in obese adolescents predicts impaired glucose tolerance and nonalcoholic fatty liver disease. J Adolesc Health 42: 543–548.
[3]
Dunn W, Xu R, Wingard DL, Rogers C, Angulo P, et al. (2008) Suspected nonalcoholic fatty liver disease and mortality risk in a population-based cohort study. Am J Gastroenterol 103: 2263–2271.
[4]
Krawczyk M, Bonfrate L, Portincasa P (2010) Nonalcoholic fatty liver disease. Best Pract Res Clin Gastroenterol 24: 695–708.
[5]
Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, et al. (2012) The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 55: 2005–2023.
[6]
Grattagliano I, Ubaldi E, Napoli L, Marulli CF, Nebiacolombo C, et al. (2013) Utility of noninvasive methods for the characterization of nonalcoholic liver steatosis in the family practice. The "VARES" Italian multicenter study. Ann Hepatol 12: 70–77.
[7]
Third Report of the National Cholesterol Education Program (NCEP) (2002) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106: 3143–3421.
[8]
Basaranoglu M, Basaranoglu G, Sabuncu T, Senturk H (2013) Fructose as a key player in the development of fatty liver disease. World J Gastroenterol 19: 1166–1172.
[9]
Younossi ZM (2008) Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Aliment Pharmacol Ther 28: 2–12.
[10]
Agre P (2004) Aquaporin water channels (Nobel Lecture). Angew Chem Int Ed Engl 43: 4278–4290.
[11]
Hara-Chikuma M, Verkman AS (2006) Physiological roles of glycerol-transporting aquaporins: the aquaglyceroporins. Cell Mol Life Sci 63: 1386–1392.
[12]
Gena P, Pellegrini-Calace M, Biasco A, Svelto M, Calamita G (2011) Aquaporin Membrane Channels: Biophysics, Classification, Functions, and Possible Biotechnological Applications. Food Biophysics 6: 241–249.
[13]
Jelen S, Wacker S, Aponte-Santamaria C, Skott M, Rojek A, et al. (2011) Aquaporin-9 protein is the primary route of hepatocyte glycerol uptake for glycerol gluconeogenesis in mice. J Biol Chem 286: 44319–44325.
[14]
Calamita G, Gena P, Ferri D, Rosito A, Rojek A, et al. (2012) Biophysical assessment of aquaporin-9 as principal facilitative pathway in mouse liver import of glucogenetic glycerol. Biol Cell 104: 342–351.
[15]
Kuriyama H, Shimomura I, Kishida K, Kondo H, Furuyama N, et al. (2002) Coordinated regulation of fat-specific and liver-specific glycerol channels, aquaporin adipose and aquaporin 9. Diabetes 51: 2915–2921.
[16]
Carbrey JM, Gorelick-Feldman DA, Kozono D, Praetorius J, Nielsen S, et al. (2003) Aquaglyceroporin AQP9: solute permeation and metabolic control of expression in liver. Proc Natl Acad Sci U S A 100: 2945–2950.
[17]
Rojek AM, Skowronski MT, Fuchtbauer EM, Fuchtbauer AC, Fenton RA, et al. (2007) Defective glycerol metabolism in aquaporin 9 (AQP9) knockout mice. Proc Natl Acad Sci U S A 104: 3609–3614.
[18]
Lebeck J, Gena P, O'Neill H, Skowronski MT, Lund S, et al. (2012) Estrogen prevents increased hepatic aquaporin-9 expression and glycerol uptake during starvation. Am J Physiol Gastrointest Liver Physiol 302: G365–374.
[19]
Maeda N (2012) Implications of aquaglyceroporins 7 and 9 in glycerol metabolism and metabolic syndrome. Mol Aspects Med 33: 665–675.
[20]
Portois L, Zhang Y, Ladriere L, Perret J, Louchami K, et al. (2012) Perturbation of glycerol metabolism in hepatocytes from n3-PUFA-depleted rats. Int J Mol Med 29: 1121–1126.
[21]
Elkjaer M, Vajda Z, Nejsum LN, Kwon T, Jensen UB, et al. (2000) Immunolocalization of AQP9 in liver, epididymis, testis, spleen, and brain. Biochem Biophys Res Commun 276: 1118–1128.
[22]
Pastor-Soler N, Bagnis C, Sabolic I, Tyszkowski R, McKee M, et al. (2001) Aquaporin 9 expression along the male reproductive tract. Biol Reprod 65: 384–393.
[23]
Badaut J, Regli L (2004) Distribution and possible roles of aquaporin 9 in the brain. Neuroscience 129: 971–981.
[24]
Rodriguez A, Catalan V, Gomez-Ambrosi J, Garcia-Navarro S, Rotellar F, et al. (2011) Insulin- and leptin-mediated control of aquaglyceroporins in human adipocytes and hepatocytes is mediated via the PI3K/Akt/mTOR signaling cascade. J Clin Endocrinol Metab 96: E586–597.
[25]
Catalan V, Gomez-Ambrosi J, Pastor C, Rotellar F, Silva C, et al. (2008) Influence of morbid obesity and insulin resistance on gene expression levels of AQP7 in visceral adipose tissue and AQP9 in liver. Obes Surg 18: 695–701.
[26]
Miranda M, Ceperuelo-Mallafre V, Lecube A, Hernandez C, Chacon MR, et al. (2009) Gene expression of paired abdominal adipose AQP7 and liver AQP9 in patients with morbid obesity: relationship with glucose abnormalities. Metabolism 58: 1762–1768.
[27]
Calamita G, Portincasa P (2007) Present and future therapeutic strategies in non-alcoholic fatty liver disease. Expert Opin Ther Targets 11: 1231–1249.
[28]
Cai C, Wang C, Ji W, Liu B, Kang Y, et al. (2013) Knockdown of hepatic aquaglyceroporin-9 alleviates high fat diet-induced non-alcoholic fatty liver disease in rats. Int Immunopharmacol 15: 550–556.
[29]
Yang SQ, Lin HZ, Mandal AK, Huang J, Diehl AM (2001) Disrupted signaling and inhibited regeneration in obese mice with fatty livers: implications for nonalcoholic fatty liver disease pathophysiology. Hepatology 34: 694–706.
[30]
Calamita G, Ferri D, Gena P, Carreras FI, Liquori GE, et al. (2008) Altered expression and distribution of aquaporin-9 in the liver of rat with obstructive extrahepatic cholestasis. Am J Physiol Gastrointest Liver Physiol 295: G682–690.
[31]
Liquori GE, Calamita G, Cascella D, Mastrodonato M, Portincasa P, et al. (2009) An innovative methodology for the automated morphometric and quantitative estimation of liver steatosis. Histol Histopathol 24: 49–60.
[32]
Calamita G, Ferri D, Gena P, Liquori GE, Cavalier A, et al. (2005) The inner mitochondrial membrane has aquaporin-8 water channels and is highly permeable to water. J Biol Chem 280: 17149–17153.
[33]
Yang SQ, Lin HZ, Lane MD, Clemens M, Diehl AM (1997) Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis. Proc Natl Acad Sci U S A 94: 2557–2562.
[34]
Lee CS, Ho DV, Chan JY (2013) Nuclear factor-erythroid 2-related factor 1 regulates expression of proteasome genes in hepatocytes and protects against endoplasmic reticulum stress and steatosis in mice. FEBS J 15: 3609–3620.
[35]
Blomme B, Van Steenkiste C, Callewaert N, Van Vlierberghe H (2009) Alteration of protein glycosylation in liver diseases. J Hepatol. 50: 592–603.
[36]
Rojek A, Füchtbauer EM, Füchtbauer A, Jelen S, Malmendal A, et al. (2013) Liver-specific Aquaporin 11 knockout mice show rapid vacuolization of the rough endoplasmic reticulum in periportal hepatocytes after amino acid feeding. Am J Physiol Gastrointest Liver Physiol 304: G501–515.
[37]
Li CC, Lin EC (1983) Glycerol transport and phosphorylation by rat hepatocytes. J Cell Physiol 117: 230–234.
[38]
Jelen S, Gena P, Lebeck J, Rojek A, Praetorius J, et al. (2012) Aquaporin-9 and urea transporter-A gene deletions affect urea transmembrane passage in murine hepatocytes. Am J Physiol Gastrointest Liver Physiol. 303: G1279–1287.
[39]
Lee DH, Park DB, Lee YK, An CS, Oh YS, et al. (2005) The effects of thiazolidinedione treatment on the regulations of aquaglyceroporins and glycerol kinase in OLETF rats. Metabolism 54: 1282–1289.
[40]
Rodríguez A, Catalán V, Gómez-Ambrosi J, Frühbeck G (2006) Role of aquaporin-7 in the pathophysiological control of fat accumulation in mice. FEBS Lett 580: 4771–4776.
